Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
0.03-0.04
General Information
Version
2.2
Revision date
2023-07-04
Product name
Inigo
1.2.1 Relevant identified uses
Professional use
Emergency telephone
+32(0)14584545
Icons in SDS
Company Information
company name
Certis Belchim B.V.
e-mail address of the competent person responsible for the Safety Data Sheet
info.uk@certisbelchim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H373, H400, H410
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Suspected of causing cancer. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Very toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS08 GHS09
Signal word
Warning
Hazard statements
H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P273 - Avoid release to the environment. P280 - Wear protective gloves, protective clothing. P301+P312 - IF SWALLOWED: Call a POISON CENTER, doctor if you feel unwell. P308+P313 - IF exposed or concerned: Get medical advice/attention. P391 - Collect spillage. P501 - Dispose of contents/container to a licensed hazardous-waste disposal contractor or collection site except for empty clean containers which can be disposed of as non- hazardous waste.
Supplemental label elements
EUH208 - Contains Metobromuron and 1,2-benzisothiazolin-3-one. May produce an allergic reaction. EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
